Skip to main content
Erschienen in: Journal of Community Health 5/2020

11.05.2020 | Original Paper

Parent-Level Barriers and Facilitators to HPV Vaccine Implementation in Santo Domingo, Dominican Republic

verfasst von: Erica Liebermann, Nancy Van Devanter, Natalia Frías Gúzman, Danielle Ompad, Taraneh Shirazian, Cheryl Healton

Erschienen in: Journal of Community Health | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer is the second leading cause of cancer death for women in the Dominican Republic. Vaccination against human papillomavirus (HPV) could reduce mortality from cervical cancer globally by as much as 90%. The purpose of our study was to explore multi-level barriers and facilitators to implementation of a national HPV vaccine program in the Dominican Republic; this article focuses on parent-level barriers and facilitators. In this qualitative study, we conducted six focus groups (N = 64) with parents of school-age children in the Santo Domingo area of the Dominican Republic, representing diverse socioeconomic groups and geographic settings. Thematic content analysis, using inductive and deductive approaches, was done following transcription and translation of audio-recordings from focus group discussions. Among this group of parents in the Santo Domingo area, facilitators to vaccine uptake were favorable attitudes towards vaccines in general and concern about cervical cancer as a health issue. Barriers found were low to moderate knowledge of HPV and cervical cancer, especially in the rural and suburban groups, and cost and lack of public awareness of the vaccine. This study identified key barriers and facilitators to HPV vaccine implementation in the Dominican Republic. Health messaging, incorporating specialist providers as opinion leaders, will need to be tailored to broad audiences with varying levels of information and awareness, anticipating misinformation and concerns, and will need to emphasize HPV vaccine as a method to prevent cancer.
Literatur
1.
Zurück zum Zitat Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
2.
Zurück zum Zitat Castle, P. E., & Maza, M. (2015). Prophylactic HPV vaccination: past, present, and future. Epidemiology and Infection, 2, 1–20. Castle, P. E., & Maza, M. (2015). Prophylactic HPV vaccination: past, present, and future. Epidemiology and Infection, 2, 1–20.
4.
Zurück zum Zitat Kavanagh, K., Pollock, K. G., Cuschieri, K., Palmer, T., Cameron, R. L., Watt, C., et al. (2017). Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: A 7-year cross-sectional study. The Lancet Infectious Diseases, 17(12), 1293–1302. https://doi.org/10.1016/S1473-3099(17)30468-1.CrossRefPubMed Kavanagh, K., Pollock, K. G., Cuschieri, K., Palmer, T., Cameron, R. L., Watt, C., et al. (2017). Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: A 7-year cross-sectional study. The Lancet Infectious Diseases, 17(12), 1293–1302. https://​doi.​org/​10.​1016/​S1473-3099(17)30468-1.CrossRefPubMed
6.
Zurück zum Zitat Wigle, J., Fontenot, H. B., & Zimet, G. D. (2016). Global delivery of human papillomavirus vaccines. Pediatric Clinics of North America, 63(1), 81–95.CrossRef Wigle, J., Fontenot, H. B., & Zimet, G. D. (2016). Global delivery of human papillomavirus vaccines. Pediatric Clinics of North America, 63(1), 81–95.CrossRef
12.
Zurück zum Zitat Miles, M. B., Huberman, A. M., & Saldaña, J. (2014). Qualitative data analysis: A methods sourcebook (3rd ed.). Thousand Oaks, CA: SAGE Publications, Inc. Miles, M. B., Huberman, A. M., & Saldaña, J. (2014). Qualitative data analysis: A methods sourcebook (3rd ed.). Thousand Oaks, CA: SAGE Publications, Inc.
13.
Zurück zum Zitat Patton, M. Q., & Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks, CA: Sage Publications. Patton, M. Q., & Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks, CA: Sage Publications.
14.
Zurück zum Zitat Liebermann, E. J., VanDevanter, N., Shirazian, T., FríasGúzman, N., Niles, M., Healton, C., et al. (2019). Barriers to cervical cancer screening and treatment in the Dominican Republic: Perspectives of focus group participants in the Santo Domingo area. Journal of Transcultural Nursing. https://doi.org/10.1177/1043659619846247.CrossRefPubMed Liebermann, E. J., VanDevanter, N., Shirazian, T., FríasGúzman, N., Niles, M., Healton, C., et al. (2019). Barriers to cervical cancer screening and treatment in the Dominican Republic: Perspectives of focus group participants in the Santo Domingo area. Journal of Transcultural Nursing. https://​doi.​org/​10.​1177/​1043659619846247​.CrossRefPubMed
15.
Zurück zum Zitat Bartolini, R. M., Drake, J. K., Creed-Kanashiro, H. M., Díaz-Otoya, M. M., Mosqueira-Lovón, N. R., Penny, M. E., et al. (2010). Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica de Mexico, 52(3), 226–233.CrossRef Bartolini, R. M., Drake, J. K., Creed-Kanashiro, H. M., Díaz-Otoya, M. M., Mosqueira-Lovón, N. R., Penny, M. E., et al. (2010). Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica de Mexico, 52(3), 226–233.CrossRef
16.
Zurück zum Zitat Howard, N., Mounier-Jack, S., Gallagher, K. E., Kabakama, S., Griffiths, U. K., Feletto, M., et al. (2016). The value of demonstration projects for new interventions: the case of human papillomavirus vaccine introduction in low and middle-income countries. Human Vaccines & Immunotherapeutics, 12, 2475–2477.CrossRef Howard, N., Mounier-Jack, S., Gallagher, K. E., Kabakama, S., Griffiths, U. K., Feletto, M., et al. (2016). The value of demonstration projects for new interventions: the case of human papillomavirus vaccine introduction in low and middle-income countries. Human Vaccines & Immunotherapeutics, 12, 2475–2477.CrossRef
Metadaten
Titel
Parent-Level Barriers and Facilitators to HPV Vaccine Implementation in Santo Domingo, Dominican Republic
verfasst von
Erica Liebermann
Nancy Van Devanter
Natalia Frías Gúzman
Danielle Ompad
Taraneh Shirazian
Cheryl Healton
Publikationsdatum
11.05.2020
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 5/2020
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-020-00830-y

Weitere Artikel der Ausgabe 5/2020

Journal of Community Health 5/2020 Zur Ausgabe